Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women aged between 45 and 74 years old.
- Women who have no symptoms or signs of breast cancer.
- Women who are considered at average risk for breast cancer — meaning no known BRCA1, BRCA2, or TP53 gene mutations, and no previous history of breast cancer.
- Women who have had a standard mammogram (either a traditional 2D mammogram or a 3D tomosynthesis scan, covering both breasts) within the past month with results available, or who have one planned for the same day as the MammoWave test or shortly after.
- Women who are willing to follow the study procedures and recommendations.
- Women who have signed a consent form before taking part in any study activity.
Who may not be able to join:
- Women who have breast implants or prostheses.
- Women who have symptoms or signs of suspected breast cancer.
- Women with known BRCA1, BRCA2, or TP53 gene mutations, or who have previously had breast cancer.
- Women who are pregnant.
- Women whose breast cancer is known to show no signs in the breast itself — for example, where a tumour is only detectable through the armpit (confirm with trial site).
- Women whose breast size is larger than the largest available cup size for the MammoWave device.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 0039 3490564302
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
MammoWave® sensitivity; MammoWave® specificity
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.